Clinical Trial Update: Study of Voreloxin (Vosaroxin) in Older Patients With Untreated Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

Phase 2 results update for Vosaroxin (Voreloxin) in older patients with untreated acute myeloid leukemia; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Voreloxin (vosaroxin)

Snippet

Sponsor: Sunesis Pharmaceuticals | Conditions: Leukemia, Acute Disease | Phase 2 | Status: COMPLETED | Results posted: 2017-06-28